Form 8-K - Current report:
SEC Accession No. 0000950170-24-112734
Filing Date
2024-10-04
Accepted
2024-10-04 09:00:07
Documents
11
Period of Report
2024-09-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alxo-20240930.htm   iXBRL 8-K 50860
  Complete submission text file 0000950170-24-112734.txt   164977

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alxo-20240930.xsd EX-101.SCH 25860
13 EXTRACTED XBRL INSTANCE DOCUMENT alxo-20240930_htm.xml XML 4539
Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

EIN.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39386 | Film No.: 241353646
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)